UA78110U - method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes - Google Patents

method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes

Info

Publication number
UA78110U
UA78110U UAU201210032U UAU201210032U UA78110U UA 78110 U UA78110 U UA 78110U UA U201210032 U UAU201210032 U UA U201210032U UA U201210032 U UAU201210032 U UA U201210032U UA 78110 U UA78110 U UA 78110U
Authority
UA
Ukraine
Prior art keywords
patients
diabetes
expression
reducing
type
Prior art date
Application number
UAU201210032U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Мар'яна Юріївна Горшунська
Юрій Іванович Караченцев
Нона Олександрівна Кравчун
Жанна Анатоліївна Лещенко
Олександр Іванович Гладких
Тетяна Василівна Тижненко
Юлія Анатоліївна Опалейко
Вікторія Віталіївна Полторак
Original Assignee
Державна Установа "Інститут Проблем Ендокринної Патології Ім. В.Я. Данилевського Національної Академії Медичних Наук України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа "Інститут Проблем Ендокринної Патології Ім. В.Я. Данилевського Національної Академії Медичних Наук України" filed Critical Державна Установа "Інститут Проблем Ендокринної Патології Ім. В.Я. Данилевського Національної Академії Медичних Наук України"
Priority to UAU201210032U priority Critical patent/UA78110U/en
Publication of UA78110U publication Critical patent/UA78110U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes by pharmacological agents. At permanent pattern of antidiabetic therapy to patients additional medication Omacora is prescribed 1 capsule daily for 3 months.
UAU201210032U 2012-08-21 2012-08-21 method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes UA78110U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201210032U UA78110U (en) 2012-08-21 2012-08-21 method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201210032U UA78110U (en) 2012-08-21 2012-08-21 method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes

Publications (1)

Publication Number Publication Date
UA78110U true UA78110U (en) 2013-03-11

Family

ID=51585967

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201210032U UA78110U (en) 2012-08-21 2012-08-21 method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes

Country Status (1)

Country Link
UA (1) UA78110U (en)

Similar Documents

Publication Publication Date Title
GEP201706719B (en) Pirfenidone treatment for patients with atypical liver function
TN2013000411A1 (en) Branched 3-phenylpropionic acid derivatives and the use thereof
PH12015500746A1 (en) Benzamides
MX2013008256A (en) Novel tetrahydroquinoline derivatives.
EP2714137A4 (en) A tunic intended to be worn by a patient undergoing infusion therapy, for use particularly by children
EP2932967A4 (en) Use of a photosensitive agent capable of producing reactive oxygen species in the production of a drug for the photodynamic therapy of a disease related to stem cells, in vitro use, and pharmaceutical composition
UA78110U (en) method for reducing the expression of cardiovascular risk factors in patients with type 2 diabetes
UA76558U (en) method for treating gastroesophageal reflux disease in patients with type 2 diabetes
UA46330U (en) Method for providing mototherapy with delayed-release hypotensive drugs to patients with metabolic syndrome
UA82542U (en) Method for treating chronic heart failure with signs of mechanical desynchronization in patients with diabetes mellitus type 2
UA80700U (en) Method for preventing resorption of alveolar process in patients with generalized periodontitis
CN103800380A (en) Chinese patent medicine for treating central retinitis
UA70033U (en) Simulation method of type 2 diabetes mellitus in rabbits
UA69222U (en) Method for reflexotherapy in patients with effects of traumatic brain injuries
UA75754U (en) method for treating patients with nonproliferative diabetic retinopathy
UA76361U (en) METHOD FOR CORRECTION OF EXPERIMENTAL DIABETIC RETINOPATHY
UA65038U (en) method for treatment of patients with tocomanias
UA53217U (en) Mask for therapy and general health improvement
UA56353U (en) method for restoration of tear-nasal canal in children with administration of drug
UA55466U (en) Method for treating metabolic disorders in patients with contusion trauma of eye
UA46402U (en) Method for diagnostic of the metabolic syndrome
UA69870U (en) Method for the treatment of vegetative sensory polyneuropathy in patients with vibration disease
UA69869U (en) Method for evaluation of anti-oxidative efficacy of 6-lipoic acid in treatment of vegeto-sensor polyneuropathy in patients with vibratory disease
UA62637U (en) method for treating vegetative and anxiety disorders in patients with the syndrome of vegetative dystonia
UA51781U (en) Method for treating chronic eczema